Breast

Papers
(The H4-Index of Breast is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Immediate breast reconstruction on overall and breast cancer-specific survival: A propensity score matched analysis2264
Editorial Board217
P473: Percutaneous Ultrasound-Guided Cryoablation for the Treatment of Breast Cancer in Non-Surgical Patients178
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines156
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients121
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes114
P229: Impact of neoadjuvant chemotherapy on early relapses of luminal stage II breast cancer105
P332: Oncological Safety and Patient Satisfaction of Immediate Lipofilling in Breast-Conserving Surgery: A Systematic Reviewand Subgroup Meta-Analysis Comparing Outcomes with No Lipofilling93
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients86
P279: Evaluation of Pathologic Complete Response (pCR) as a Surrogate for Event-Free Survival in neoadjuvant Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Early Breast Cancer (eBC)75
P309: Four Grounds for Choosing Bilateral Free DIEP Flap Breast Reconstruction in Breast Cancer with Large and Ptotic Breasts: a retrospective case-control study72
Novel models based on machine learning to predict the prognosis of metaplastic breast cancer67
Corrigendum to “Current pattern of care in radiation therapy for DCIS in Australia - where are we heading?” [The Breast 82(2025) 104482]67
Metastases of primary mixed no-special type and lobular breast cancer display an exclusive lobular histology64
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?55
Editorial Board50
Adenosquamous proliferation in radial sclerosing lesions: Histologic spectrum and key features in systematic review of 247 lesions48
Impact of stereotactic body radiation therapy on systemic therapeutic line change in oligometastatic breast cancer45
Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective45
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction45
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study45
Relationship between homologous recombination deficiency and clinical features of breast cancer based on genomic scar score42
Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target41
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer40
The continuing conundrum in oligometastatic breast carcinoma: A real-world data39
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS39
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery38
Response to comment on: “Global guidelines for breast cancer screening: A systematic review”38
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?38
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience37
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY36
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?35
No association between breast pain and breast cancer34
0.077028036117554